Zhe Qu, DVM
Beijing Key Laboratory for Safety Evaluation of Drugs, National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, Beijing 100176, China
Zhe Qu was born in Hebei Province (China) on June the 9th, 1982. She received her BVM from Agricultural University of Hebei in 2005 and got her MS and DVM from China Agricultural University in 2008 and in 2018, respectively. She has worked as a toxicological pathologist in NCSED of National Institutes for Food and Drug Control (NIFDC) for ten years. She mainly engages in toxicologic pathology examination on preclinical evaluation of drugs and has completed over 80 anatomic pathology reports submitted to CFDA and FDA. She also has finished twenty reports of tissue cross-reactivity study of antibody drugs as a study director. She has contributed to a study project of renal toxicity biomarkers in cooperation with HESI/Sanofi. Furthermore, She took part in key technology programs for non-clinical safety evaluation of innovative drugs of the 11th, 12th and 13th National Five-Year Plan for Significant New Drug Creation supported by Ministry of Science and Technology of China and has been researching in vitro alternative methods of Neurotoxicity evaluation. She undertook and completed one young scientist project supported by NIFDC. She has authored/coauthored more than 50 scientific papers in peer-reviewed journals, more than 10 oral presentations at professional academic conferences, and 5 monograph chapters.
The main areas of research include toxicologic pathology evaluation and peer review, tissue cross-reactivity study of biotechnology drugs, in vitro alternative methods study of neurotoxicity, preclinical research on CAR-T cell products.
Articles Published in the Annals of Translational Medicine